Honokiol applied to OSCC cell lines HN22 and HSC4 decreased the expression of the enzyme nitric oxide synthase (iNOS) and the level of the ERp44 ER-resident protein and inhibited the proliferation of tumour cells and colony formation. Here, ERP44 is linked to neoplasm.